It can be treated with vitamin B12 medications
None of the B12 gets lost in the digestive process
Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients
For people with absorption problems, low stomach acid, or a diagnosed deficiency, the injection route tends to work faster and more reliably
Call or Text: (682) 345-7155 Fax: (682) 323-2017 In todays busy world, energy often runs low